Key regions: Brazil, India, Australia, United States, United Kingdom
Antiviral drugs are a crucial aspect of the healthcare industry, used to treat viral infections by inhibiting the growth of viruses. The Antiviral Drugs market in Qatar is developing at a steady pace due to various underlying macroeconomic factors and local special circumstances.
Customer preferences: The demand for antiviral drugs in Qatar is primarily driven by the increasing prevalence of viral infections such as influenza, hepatitis, and HIV. Additionally, the rising awareness about the benefits of antiviral drugs among the population is also contributing to the growth of the market.
Trends in the market: One of the major trends in the Antiviral Drugs market in Qatar is the increasing adoption of combination therapies. Combination therapies involve the use of two or more antiviral drugs to treat viral infections, resulting in better outcomes and reduced risk of drug resistance. Another trend is the growing focus on research and development of novel antiviral drugs, which are more effective and have fewer side effects.
Local special circumstances: The healthcare industry in Qatar is witnessing significant growth due to the government's initiatives to improve healthcare infrastructure and services. The country is also hosting major international events such as the FIFA World Cup 2022, which is expected to boost the demand for antiviral drugs. Additionally, the high prevalence of viral infections in the region is driving the need for effective antiviral drugs.
Underlying macroeconomic factors: Qatar's economy is primarily driven by the oil and gas industry, which has been impacted by the COVID-19 pandemic. However, the healthcare industry has remained resilient, with the government allocating significant funds towards improving healthcare infrastructure and services. The government's focus on developing a knowledge-based economy and promoting research and development is also contributing to the growth of the Antiviral Drugs market in Qatar.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
